Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
205.49B
Market cap205.49B
Price-Earnings ratio
23.44
Price-Earnings ratio23.44
Dividend yield
2.63%
Dividend yield2.63%
Average volume
2.77M
Average volume2.77M
High today
$384.53
High today$384.53
Low today
$376.37
Low today$376.37
Open price
$382.52
Open price$382.52
Volume
1.09M
Volume1.09M
52 Week high
$447.03
52 Week high$447.03
52 Week low
$269.77
52 Week low$269.77

Stock Snapshot

The current Amgen(AMGN) stock price is $380.09, with a market capitalization of 205.49B. The stock trades at a price-to-earnings (P/E) ratio of 23.44 and offers a dividend yield of 2.63%.

On 2026-09-14, Amgen(AMGN) stock traded between a low of $376.37 and a high of $384.53. Shares are currently priced at $380.09, which is +1.0% above the low and -1.2% below the high.

The Amgen(AMGN)'s current trading volume is 1.09M, compared to an average daily volume of 2.77M.

In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.

In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.

AMGN News

TipRanks 1h
Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Amgen Inc (AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluat...

Nasdaq 4h
Amgen: FDA Approves Update To IMDELLTRA Prescribing Information, Cuts Monitoring Time For Two Doses

(RTTNews) - Amgen (AMGN) announced the FDA approved an update to the IMDELLTRA Prescribing Information that substantially reduces the recommended monitoring tim...

Amgen: FDA Approves Update To IMDELLTRA Prescribing Information, Cuts Monitoring Time For Two Doses
TipRanks 5h
Amgen says FDA approves update to imdelltra Prescribing Information

Amgen (AMGN) announced that the U.S. FDA approved an update to the imdelltra Prescribing Information that substantially reduces the recommended monitoring time...

Analyst ratings

56%

of 36 ratings
Buy
33.3%
Hold
55.6%
Sell
11.1%

More AMGN News

Nasdaq 7h
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Amgen maintains a massive, diversified portfolio of medicines serving approximately 17 million patients globally. Vertex Pharmaceuticals dominates...

Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Investor's Business Daily 3d
AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer

Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? 8/27/2026 Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease t...

AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer
Nasdaq 3d
Dow Movers: AMGN, HONIV

In early trading on Friday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7...

Dow Movers: AMGN, HONIV
TipRanks 4d
Amgen’s New Repatha Plaque Trial: What Investors Should Watch

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a Phase 4 trial called “A Trial Assessing the Effectivenes...

The Wall Street Journal 6d
💬 Money Quote: A Bad Day for Amgen Stock

📣 “This is the worst possible outcome for Amgen.” —Barclays analyst Emily Field, on Novartis announcing a disappointing result for its heart disease drug, a di...

💬 Money Quote: A Bad Day for Amgen Stock
The Motley Fool 6d
Stock Market Today, Sept. 8: Stocks Slide Amid Surging Oil Prices, Persistent Geopolotical Tenisons

The Dow Jones Industrial Average (^DJI -1.18%) fell 1.18% to 52,786, the S&P 500 (^GSPC -0.58%) lost 0.58% to 7,674, and the Nasdaq Composite (^IXIC -0.32%) dro...

Stock Market Today, Sept. 8: Stocks Slide Amid Surging Oil Prices, Persistent Geopolotical Tenisons
TipRanks 6d
S&P 500 Top Stock Gainers Today, 9/8/26

The S&P 500 (SPX) closed down 0.55% on Monday amid higher oil prices and elevated rate hike expectations. Let’s break down the sectors behind the performance....

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.